Securian Asset Management Revenue and Competitors

Location

N/A

Total Funding

Investments

Industry

Estimated Revenue & Valuation

  • Securian Asset Management's estimated annual revenue is currently $21.6M per year.(i)
  • Securian Asset Management's estimated revenue per employee is $227,000

Employee Data

  • Securian Asset Management has 95 Employees.(i)
  • Securian Asset Management grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M759%N/AN/A
#2
$87.1M3072%N/AN/A
#3
$4.6M29-6%N/AN/A
#4
$20.2M890%N/AN/A
#5
$7.8M435%N/AN/A
#6
$11.6M57-25%N/AN/A
#7
$7.1M0N/AN/AN/A
#8
$8M4433%N/AN/A
#9
$71.4M286-10%N/AN/A
#10
$2.3M17N/AN/AN/A
Add Company

Securian Asset Management, Inc. and its predecessors have been providing investment management services for decades. Founded in 1984, with an investment history dating back to 1880, we combine active investment management with a collaborative, research-driven culture to develop tailored investment solutions for institutional clients. Our investment strategy expertise includes focus on fixed income, liability-driven investing, managed volatility, private placements, commercial real estate, real estate securities, and income-oriented equity strategies. Securian Asset Management is a subsidiary of Securian Financial Group, Inc. and is formerly known as Advantus Capital Management, Inc. The firm changed its name in 2018 to more closely align with its parent company, and its commitment to the asset management business.

keywords:Finance

N/A

Total Funding

95

Number of Employees

$21.6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Securian Asset Management News

2022-04-17 - Halozyme Therapeutics, Inc. (NASDAQ:HALO) Receives ...

Securian Asset Management Inc. now owns 12,764 shares of the biopharmaceutical company's stock valued at $519,000 after buying an additional 464...

2022-04-17 - Tandem Diabetes Care, Inc. Expected to Earn Q1 2022 ...

Securian Asset Management Inc. now owns 5,752 shares of the medical device company's stock worth $866,000 after acquiring an additional 100...

2022-04-17 - Halozyme Therapeutics (NASDAQ:HALO) Downgraded to ...

Securian Asset Management Inc. now owns 12,764 shares of the biopharmaceutical company's stock valued at $519,000 after acquiring an additional...

2019-09-08 - Medical Properties Trust, Inc. (NYSE:MPW) Shares Purchased by Securian Asset Management Inc

Securian Asset Management Inc lifted its position in Medical Properties Trust, Inc. (NYSE:MPW) by 2.0% in the 2nd quarter, according to the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M9714%N/A
#2
$17.5M97-3%N/A
#3
$15M9836%N/A
#4
$15M9840%N/A
#5
$29.3M1015%N/A